US Patent

US10022502 — Dose guides for injection syringe

Method of Use · Assigned to Icon Bioscience Inc · Expires 2034-06-22 · 8y remaining

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects devices that guide the accurate loading and dispensing of predetermined doses of fluid from injection syringes.

USPTO Abstract

Devices that guide the accurate loading and dispensing of predetermined doses of fluid from injection syringes are disclosed.

Drugs covered by this patent

Decadron (dexamethasone) · Generic (originally Merck)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2340`	—	Decadron

Patent Metadata

Patent number: US10022502
Jurisdiction: US
Classification: Method of Use
Expires: 2034-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Icon Bioscience Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.